Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Genus plc ( (GB:GNS) ) is now available.
Genus plc announced that Mark Birri, the Chief Corporate Development Officer, sold 700 ordinary shares from his Individual Savings Account on September 18, 2025. This transaction was conducted on the London Stock Exchange and is reported in compliance with the Market Abuse Regulation. The sale of shares by a senior executive might indicate a personal financial decision and does not necessarily reflect the company’s operational or market strategy.
The most recent analyst rating on (GB:GNS) stock is a Buy with a £2900.00 price target. To see the full list of analyst forecasts on Genus plc stock, see the GB:GNS Stock Forecast page.
Spark’s Take on GB:GNS Stock
According to Spark, TipRanks’ AI Analyst, GB:GNS is a Outperform.
Genus plc’s overall stock score is driven by strong financial performance and positive technical indicators. The company’s strategic progress and optimistic outlook from the earnings call further support the score. However, a high P/E ratio suggests potential overvaluation, which tempers the overall assessment.
To see Spark’s full report on GB:GNS stock, click here.
More about Genus plc
Genus plc operates in the biotechnology industry, focusing primarily on animal genetics and breeding. The company is known for its innovative solutions in livestock reproduction and genetic improvement, catering to agricultural markets worldwide.
Average Trading Volume: 155,197
Technical Sentiment Signal: Buy
Current Market Cap: £1.67B
Learn more about GNS stock on TipRanks’ Stock Analysis page.